Brenda Waning
- Economics and Econometrics top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Infectious Diseases top 10%
- Public Health, Environmental and Occupational Health
- Management of Technology and Innovation top 5%
- Co-authors
- Richard LaingNathan FordEllen ‘t HoenAndy GraySuerie MoonTill BärnighausenMargaret KyleYun Li
- Topics
- Pharmaceutical Economics and Policy (9 papers)HIV/AIDS Research and Interventions (5 papers)HIV/AIDS drug development and treatment (5 papers)
- Cited by
- Applied Microbiology and BiotechnologyBusiness and International ManagementEconomics and Econometrics
- Partner nations
- United StatesNetherlandsSouth Africa
In The Last Decade
Brenda Waning
13 papers receiving 489 citations
Peers
Comparison fields: 5 of 83
- Economics and Econometrics 321
- Pediatrics, Perinatology and Child Health 132
- Infectious Diseases 128
- Public Health, Environmental and Occupational Health 84
- Management of Technology and Innovation 69
Countries citing papers authored by Brenda Waning
This map shows the geographic impact of Brenda Waning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Waning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Waning more than expected).
Fields of papers citing papers by Brenda Waning
This network shows the impact of papers produced by Brenda Waning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Waning. The network helps show where Brenda Waning may publish in the future.
Co-authorship network of co-authors of Brenda Waning
This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Waning. A scholar is included among the top collaborators of Brenda Waning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Waning. Brenda Waning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 23 | |
| 3 | 4 | |
| 4 | 41 | |
| 5 | 6 | |
| 6 | 26 | |
| 7 | 82 | |
| 8 | 9 | |
| 9 | 88 | |
| 10 | 11 | |
| 11 | Transparency and Accountability in an Electronic Era: The Case of Pharmaceutical Procurements | 3 |
| 12 | 222 | |
| 13 | Pharmacoepidemiology: Principles and Practice | 6 |
About Brenda Waning
Brenda Waning is a scholar working on Economics and Econometrics, Infectious Diseases and Finance, having authored 13 papers that have together received 527 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (9 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (24 citations), Business and International Management (23 citations) and Economics and Econometrics (321 citations). Brenda Waning has collaborated with scholars based in United States, Netherlands and South Africa. Frequent co-authors include Richard Laing, Nathan Ford, Ellen ‘t Hoen, Andy Gray, Suerie Moon, Till Bärnighausen, Margaret Kyle, Yun Li, Elodie Jambert and Vivian Cox. Their work appears in journals such as The Lancet, PLoS ONE and BMC Health Services Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.